Nuvectis Pharma Inc. (NVCT)
5.46
-0.18 (-3.19%)
At close: Jan 15, 2025, 3:59 PM
5.37
-1.65%
After-hours Jan 15, 2025, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 |
| Net Income | -22.26M | -19.09M | -12.89M | -24.00K |
| Depreciation & Amortization | n/a | n/a | n/a | n/a |
| Stock-Based Compensation | 4.71M | 1.71M | 1.89M | n/a |
| Other Working Capital | 1.88M | -321.00K | -91.00K | 10.00K |
| Other Non-Cash Items | -139.00K | -2.43M | 307.00K | 24.00K |
| Deferred Income Tax | n/a | n/a | n/a | n/a |
| Change in Working Capital | 1.74M | 3.82M | 1.49M | 10.00K |
| Operating Cash Flow | -15.95M | -13.56M | -9.50M | 24.00K |
| Capital Expenditures | n/a | n/a | n/a | n/a |
| Acquisitions | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a |
| Investing Cash Flow | n/a | n/a | n/a | n/a |
| Debt Repayment | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 9.80M | -4.07M | 15.25M | n/a |
| Financial Cash Flow | 15.09M | 27.81M | 15.25M | n/a |
| Net Cash Flow | -867.00K | 14.25M | 5.74M | 24.00K |
| Free Cash Flow | -15.95M | -13.56M | -9.50M | 24.00K |